311 filings
Page 3 of 16
4
k59qujw1
20 Dec 23
Nurix Therapeutics / Houte Hans van ownership change
4:55pm
144
r7efmaz75x44q
19 Dec 23
Notice of proposed sale of securities
4:19pm
8-K
aaatjnvm tdyezicj1k
11 Dec 23
Other Events
12:03pm
8-K
7ry8 8oa28y48z0uzts
13 Nov 23
Regulation FD Disclosure
7:01am
4
yxyeojdbpwv7iapdcta
1 Nov 23
Nurix Therapeutics / Houte Hans van ownership change
4:41pm
4
3cer7b9 o7o
1 Nov 23
Nurix Therapeutics / Christine Ring ownership change
4:40pm
4
cv7g53oieu0
1 Nov 23
Nurix Therapeutics / Gwenn Hansen ownership change
4:40pm
8-K
86whw
1 Nov 23
Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 Trial
4:02pm
8-K
hza ripxf
12 Oct 23
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:03pm
8-K
yesfip pbi50bgeo
7 Sep 23
Entry into a Material Definitive Agreement
7:02am
4
x3ddyeumuim ksj61ij
1 Aug 23
Nurix Therapeutics / Houte Hans van ownership change
4:28pm
4
im7fzlcg38x6w
1 Aug 23
Nurix Therapeutics / Christine Ring ownership change
4:27pm
4
ly4lg9ioq roz9zw
1 Aug 23
Nurix Therapeutics / Gwenn Hansen ownership change
4:26pm
8-K
vvr2cds
13 Jul 23
Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
4:18pm
4
afpedd8
4 May 23
Nurix Therapeutics / Paul M Silva ownership change
8:00pm
4
xt1irjoyt pz5chuqj
4 May 23
Nurix Therapeutics / Edward C Saltzman ownership change
7:58pm
4
3dokwg 9xl
4 May 23
Nurix Therapeutics / Judith A Reinsdorf ownership change
7:58pm
4
682ecpoj23orgsja
4 May 23
Nurix Therapeutics / David L. Lacey ownership change
7:57pm